Evidence-based medicine and the role of the private sector in assisted reproduction: a response to Dr Fishel's commentary 'Evidenced-based medicine and the role of the National Health Service in assisted reproduction'

Peter Braude; Yakoub Khalaf

doi:10.1016/j.rbmo.2013.08.006

Evidence-based medicine and the role of the private sector in assisted reproduction: a response to Dr Fishel's commentary 'Evidenced-based medicine and the role of the National Health Service in assisted reproduction'

Peter Braude^*, Yakoub Khalaf

^*Corresponding author for this work

Women & Children's Health

Research output: Contribution to journal › Editorial › peer-review

1 Citation (Scopus)

Abstract

We respond to Dr Fishel's commentary on evidenced-based medicine in assisted reproduction and the role of the UK's National Health Service. We agree that proper randomised clinical trials are not easy to set up or execute. Recruitment is also challenging but requires that all personnel involved in the study, clinicians, embryologists and nurses, agree with its aims and buy in to the need for an answer. Those who believe fervently in the method under scrutiny prior to the availability of robust evidence are likely to undermine the success of any trial. New technologies are not necessarily better technologies. Neither is the supposed ` logic' of a treatment nor anecdotal clinical experience a substitute for evidence properly gained and fairly demonstrated. Dr Fishel would agree that the first obligation of healthcare professionals, whether they are in the public or private sector, is not to do harm to their patients. Adopting new interventions without rigorous assessment of the potential for harm flies in the face of this basic principle.

Original language	English
Pages (from-to)	570-572
Number of pages	3
Journal	REPRODUCTIVE BIOMEDICINE ONLINE
Volume	27
Issue number	5
DOIs	https://doi.org/10.1016/j.rbmo.2013.08.006
Publication status	Published - Nov 2013

Keywords

assisted reproductive technology
evidenced-based medicine
fervent belief
National Health Service
private sector
public funding

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.rbmo.2013.08.006

Fingerprint

Dive into the research topics of 'Evidence-based medicine and the role of the private sector in assisted reproduction: a response to Dr Fishel's commentary 'Evidenced-based medicine and the role of the National Health Service in assisted reproduction''. Together they form a unique fingerprint.

Cite this

@article{d7b63cf95b764847ad2237ea737e7ad2,

title = "Evidence-based medicine and the role of the private sector in assisted reproduction: a response to Dr Fishel's commentary 'Evidenced-based medicine and the role of the National Health Service in assisted reproduction'",

abstract = "We respond to Dr Fishel's commentary on evidenced-based medicine in assisted reproduction and the role of the UK's National Health Service. We agree that proper randomised clinical trials are not easy to set up or execute. Recruitment is also challenging but requires that all personnel involved in the study, clinicians, embryologists and nurses, agree with its aims and buy in to the need for an answer. Those who believe fervently in the method under scrutiny prior to the availability of robust evidence are likely to undermine the success of any trial. New technologies are not necessarily better technologies. Neither is the supposed ` logic' of a treatment nor anecdotal clinical experience a substitute for evidence properly gained and fairly demonstrated. Dr Fishel would agree that the first obligation of healthcare professionals, whether they are in the public or private sector, is not to do harm to their patients. Adopting new interventions without rigorous assessment of the potential for harm flies in the face of this basic principle.",

keywords = "assisted reproductive technology, evidenced-based medicine, fervent belief, National Health Service, private sector, public funding",

author = "Peter Braude and Yakoub Khalaf",

year = "2013",

month = nov,

doi = "10.1016/j.rbmo.2013.08.006",

language = "English",

volume = "27",

pages = "570--572",

journal = "REPRODUCTIVE BIOMEDICINE ONLINE",

issn = "1472-6483",

publisher = "Elsevier",

number = "5",

}

Evidence-based medicine and the role of the private sector in assisted reproduction: a response to Dr Fishel's commentary 'Evidenced-based medicine and the role of the National Health Service in assisted reproduction'. / Braude, Peter ; Khalaf, Yakoub.
In: REPRODUCTIVE BIOMEDICINE ONLINE, Vol. 27, No. 5, 11.2013, p. 570-572.

Research output: Contribution to journal › Editorial › peer-review

TY - JOUR

T1 - Evidence-based medicine and the role of the private sector in assisted reproduction

T2 - a response to Dr Fishel's commentary 'Evidenced-based medicine and the role of the National Health Service in assisted reproduction'

AU - Braude, Peter

AU - Khalaf, Yakoub

PY - 2013/11

Y1 - 2013/11

N2 - We respond to Dr Fishel's commentary on evidenced-based medicine in assisted reproduction and the role of the UK's National Health Service. We agree that proper randomised clinical trials are not easy to set up or execute. Recruitment is also challenging but requires that all personnel involved in the study, clinicians, embryologists and nurses, agree with its aims and buy in to the need for an answer. Those who believe fervently in the method under scrutiny prior to the availability of robust evidence are likely to undermine the success of any trial. New technologies are not necessarily better technologies. Neither is the supposed ` logic' of a treatment nor anecdotal clinical experience a substitute for evidence properly gained and fairly demonstrated. Dr Fishel would agree that the first obligation of healthcare professionals, whether they are in the public or private sector, is not to do harm to their patients. Adopting new interventions without rigorous assessment of the potential for harm flies in the face of this basic principle.

AB - We respond to Dr Fishel's commentary on evidenced-based medicine in assisted reproduction and the role of the UK's National Health Service. We agree that proper randomised clinical trials are not easy to set up or execute. Recruitment is also challenging but requires that all personnel involved in the study, clinicians, embryologists and nurses, agree with its aims and buy in to the need for an answer. Those who believe fervently in the method under scrutiny prior to the availability of robust evidence are likely to undermine the success of any trial. New technologies are not necessarily better technologies. Neither is the supposed ` logic' of a treatment nor anecdotal clinical experience a substitute for evidence properly gained and fairly demonstrated. Dr Fishel would agree that the first obligation of healthcare professionals, whether they are in the public or private sector, is not to do harm to their patients. Adopting new interventions without rigorous assessment of the potential for harm flies in the face of this basic principle.

KW - assisted reproductive technology

KW - evidenced-based medicine

KW - fervent belief

KW - National Health Service

KW - private sector

KW - public funding

U2 - 10.1016/j.rbmo.2013.08.006

DO - 10.1016/j.rbmo.2013.08.006

M3 - Editorial

SN - 1472-6483

VL - 27

SP - 570

EP - 572

JO - REPRODUCTIVE BIOMEDICINE ONLINE

JF - REPRODUCTIVE BIOMEDICINE ONLINE

IS - 5

ER -